KEY WORDS: 5-hydroxy-4'-nitro-7-propionyloxy-genistein, invasion, metastasis, β -catenin 2 5-hydroxy-4'-nitro-7-propionyloxy-genistein inhibited invasion and metastasis via inactivating wnt/β-catenin signal pathway in human endometrial carcinoma JEC cells in vitro ABSTRACT Chemotherapy has been demonstrating more important roles in the treatment of carcinoma, but drug resistance and side effects restrict its usage in clinic, so developing new type of drug with low side effects and low-drug resistance has become a hot researching spot. The present study aimed to investigate the anticancer effects of 5-hydroxy-4'-nitro-7-propionyloxy-genistein (HNPG) and elucidate its underlying molecular mechanism. The inhibitory effects of cell viability of HNPG were detected using MTT assay, flat plate clone formation method and Transwell assay. The distribution of cell cycle was analyzed using FCM method. The morphological alteration, root-mean-squared roughness (Rq), average roughness (Ra), Young's modulus and adhesive force were measured by AFM. qRT-PCR and western blotting analysis were used to explore the possible molecular mechanism. It was found that HNPG presented with dramatic activity against JEC cells in vitro, inhibited the proliferation and colony formation, attenuated invasion and migration ability, arrested cell cycle in G1 phase in dose-dependent manner. Simultaneously, cell body shrunk and pseudopod structure retracted, Rq and Ra reduced, Young's modulus and adhesive force increased, accompanied by β -catenin, C-myc, Cyclin D1, MMP-2, MMP-7 and MMP-9 down-regulated. In summary, HNPG may be a novel candidate for chemotherapeutic drug.
INTRODUCTION
Endometrial carcinoma (EC) is a group of epithelial malignancies that occur in the endometrium, and endometrial adenocarcinoma is the most common form accounting for 80 % ~ 90 % of all pathological types (Ethier et al., 2017) . EC is one of the three malignant tumors of female genital tract, accounting for 7 % of malignant tumor in human carcinomas, and 20 % ~ 30 % of female malignant tumors (Kim et al., 2017) .
The average age suffering EC is 60 years with 75 % of patients aged 50 years or older.
The morbidity of EC has been increasing worldwide in recent years (Ding et al., 2017) , the main treatment of EC is surgery, radiotherapy, chemotherapy and hormone therapy (Ethier et al., 2017; Kim et al., 2017) . Chemotherapy is one of the most important treatment measures for the EC of late-stage and recurrence, and it can also be used to EC with high-risk factors of recurrence (Kim et al., 2017; Ding et al., 2017) .
Nowadays, chemotherapy drugs, such as cisplatin, paclitaxel, cyclophosphamide, fluorouracil, mitomycin, etoposide and so on, are commonly used in clinical chemotherapy (Lester-Coll et al., 2017) . Although chemotherapy demonstrates more and more important role in the treatment of EC, the generation of drug resistance and its side effects restrict its usage in clinic. Therefore, developing new type of drug with low side effects or without side effects and low-drug resistance has become a hot researching spot.
Genistein (GEN), one kind of isoflavone extracted from soybean, is reported that possess extensive antitumor activities via regulating oncogenes in many signal pathways, such as anti-proliferation, inhibitive metastasis, induction of apoptosis and so on (Zhong et al., 2017) . However, the lower absorption rate of gastrointestinal tract and lower biological activity limit its clinical application (Zhong et al., 2017) . It is well known that structural modification could enhance the solubility and biological activity (Chen et al., 2017) , 5-hydroxy-4'-nitro-7-propionyloxy-genistein (HNPG), a novel synthetic derivative of GEN, possesses a nitro group in C-4', a hydroxyl group at C-5 and a propionyloxy group at C-7 (Wang et al., 2012; Wang et al., 2005) , which mean HNPG possess more solubility and biological activity than its precursor GEN. It 4 was reported that HNPG exhibited an inhibition of proliferation in gastric and breast cancer, but its antitumor effect has not been examined in EC, and its molecular biological mechanism has not been investigated (Wang et al., 2012; Wang et al., 2005) .
Wnt/β-catenin signal pathway is a complex and conservative signal pathway in mammal and human, is composed of a series of interacting proteins, regulates cell proliferation, adhesion, movement and so on, plays an important role in embryo development and tissue repair (Krishnamurthy and Kurzrock, 2018; Shanmugapriya et al., 2017) . Abnormal activation of wnt/β-catenin signal pathway can cause abnormal proliferation and differentiation and result in tumor occurrence (Krishnamurthy et al., 2018) . In addition, wnt/β-catenin signal pathway may induce the process of epithelial mesenchymal transformation (EMT), and affect the progression and metastasis of carcinoma (Shanmugapriya et al., 2017) . So far, researches have shown that wnt/β-catenin signal pathway plays an important role in the occurrence of EC, and about 40 % of EC exhibit the abnormal activation of wnt/β-catenin signal pathway, especially in endometrial adenocarcinoma (EEC) (Eritja et al., 2017) . Researchers discovered that the mutation of CT-NNB1 exon-3 could cause β -catenin protein accumulation, activated wnt/β-catenin signal pathways via analyzing 271 cases of EEC patients (Liu et al., 2014) . It was reported that the expression of wnt10b was significantly increased in the tissues of EC (Chen et al., 2013) . Researchers illuminated the role of a new signal pathway of PCDH10-wnt/β-catenin-MALAT1 on occurrence and progress in EC (Zhao et al., 2014) .
In the present study, the anticancer effects of HNPG in JEC cells were evaluated in vitro, and the results demonstrated that HNPG could inhibit proliferation, clone formation, invasion and metastasis, which might attribute to HNPG increasing the cell accumulation in G1/S phase, altering cell morphological features, decreasing Rq and Ra, enhancing Young's modulus and adhesive force in JEC cells through inactivating wnt/β-catenin signal pathway, down-regulating β -catenin, C-myc, Cyclin D1, MMP-2, MMP-7 and MMP-9, which not only demonstrated the antitumor effects of HNPG, 5 but also highlighted the basic molecular biological mechanism of HNPG compared with those previous reports (Wang et al., 2012; Wang et al., 2005) . A, B).
RESULTS

HNPG inhibited the proliferation of JEC cells
HNPG changed the morphological features of JEC cells
The morphology of cells of 0.1 % DMSO group was long fusiform, the filamentous pseudopod was distributed around the cell body, and the surface of the cell membrane was relatively flat covered with granules in 60 μ m 2 × 60 μ m 2 of scan range of AFM ( Fig. 5 A, B ). The surface of the cell membrane showed the shape of flannelette blanket distributing small homogeneous bulges, the arrangement of bulges was moderate in 5μm 2 × 5 μ m 2 of scanning range, which is characterized by normal malignant tumor cells ( Fig 
HNPG decreased the root-mean-square roughness (Rq) and the average roughness (Ra) of JEC cells
The present study found that the root-mean-square roughness (Rq) of 0. Fig. 6 A, B) . mRNA expression levels. There were statistical differences among every HNPG-treated group in β -catenin, C-myc, Cyclin D1, MMP-2, and MM-7 and MMP-9 mRNA expression levels (P 2/4μM <0.05, P 2/8μM <0.05, P 4/8μM <0.05) ( Fig. 7 A,   B ).
HNPG regulated protein of wnt/β-catenin signal pathway of JEC cells.
JEC cells were exposed to 0.1 % DMSO and different concentrations of HNPG (2, 4 MMP-9, the present study not only detected the inhibiting effects of cell viability, but also elucidated the possible molecular mechanism of HNPG. In summary, HNPG indicated a marked cytotoxic activity in human endometrial carcinoma JEC cells via inactivating wnt/β-catenin signal pathway, which suggested that HNPG may be a novel candidate for chemotherapeutic drug. Subsequent studies will focus on investigating the metabolism of HNPG in experimental animal models, detecting its blood drug concentration and its half-life and the side effects on the brain, heart, lung, liver and kidney cells, and elucidate the possible molecular mechanism in vivo. 2, 0.4, 0.8, 1.6, 3.2, 6.4 and 12.8 µM, GEN of 0.5, 1, 2, 4, 8, 16, 32, 64 and 128 µM, and HNPG of 0.125, 0.25, 0.5, 1, 2, 4, 8, 16 and 32 µM for 24 h at 37 ˚C in 5 % CO 2 . Subsequently, 20 μ l 5 mg/ml MTT stock solution was added to each well and continued to culture for 6 h at 37 ˚C. A total of 100 μ l DMSO was used to stop the reaction, and spectrophotometric absorbance was subsequently measured using a microplate reader (ELX-800; Sangon Biotech Co., Ltd., Shanghai, China) at 570 nm 1 -(the mean number of HNPG group/the mean number of control group) x 100 %.
The results were representative of three independent experiments.
Transwell assay
A pre-cooled 24-well Transwell plate (Tiangen Biotech Co., Ltd., Beijing, China) was covered with 30 µl Matrigel TM at a 1:3 dilution and incubated at 37 ˚C for 3 h. Then, JEC cells (1 x 10 5 /well) were cultivated at 37 ˚C for 18 h in the inner chamber and a MultiMode; Veeco Inc., New York, US).
The radius of microcantilever probe was less than 10 nm, the force elastic coefficient of microcantilever was 5 N/m, the length or width of microcantilever was 125 μ m or 25 μ m respectively. The scan ranged from 60 μ m 2 x 60 μ m 2 to 5 μ m 2 x 5 μ m 2 , and the scanning frequency is 1 Hz. The mechanical measurement of single-cell was detected using contact mode in RPMI-1640 medium at 1.63 m/s of moving forward speed and 0.8 Hz of scanning speed. DNP-S of AFM probe was used to collect the curve of force-distance, and the resonant frequency of probe ranged from 12 kHz to 24 kHz, the force elastic coefficient of microcantilever was 0.06 N/m, the length or width of microcantilever was 205 μ m or 25 μ m respectively. At least 15 cells were selected and more than 1,000 curves of force-distance were measured in each group. Young's modulus and adhesion force of Gaussian fitting were analyzed and calculated using Nano Scope analysis software 8.14.
Quantitative real-time polymerase chain reaction (qRT-PCR)
The total RNA of JEC cells treated with 0. 
Western blotting analysis
JEC cells that were administrated to 0.1 % DMSO or different concentrations of HNPG (2, 4 and 8 µM) for 24 h were lysed in 5 % lysis buffer (Tiangen Biotech Co., Ltd., Beijing, China). The amount of total protein was determined by BCA kit (Tiangen Biotech Co., Ltd., Beijing, China). Protein (20 μ g) was separated by 10 % SDS-PAGE and transferred to nitrocellulose membranes. Non-specific binding sites were blocked by incubating the nitrocellulose membrane for 1 h at 37 ˚C with 5 % non-fat dried milk in TBST. The membranes were incubated for overnight at 4 ˚C with primary antibodies (rabbit anti-β-catenin, rabbit anti-C-myc, rabbit anti-Cyclin D1, rabbit anti-MMP-2, rabbit anti-MMP-7, rabbit anti-MMP-9 and rabbit anti-GAPDH) on shaker, then a horseradish peroxidase-conjugated secondary rabbit antibody for 1 h at 20 ˚C on shaker. Bands were visualized using an enhanced chemiluminescence system (Catalog Number: AR1170; Boster Biological Technology Co., Ltd., Wuhan, Hubei, China) and analyzed using Alpha Image 2200 (Version: 1.0;
National Institutes of Health, Maryland, US). Each experiment was repeated three times and the mean value was obtained. Data are presented as the mean ± standard deviation. The means of multiple groups were compared with one-way analysis of variance (ANOVA), P<0.05 was considered to indicate a statistically significant difference. 
